“Effectiveness and Safety of First-Generation Protease Inhibitors in Real-World Patients With Hepatitis C Virus Genotype 1 Infection in Brazil: A Multicenter Study”. Clinics 72, no. 6 (June 1, 2017): 378–385. Accessed April 27, 2024. https://revistas.usp.br/clinics/article/view/134124.